Background: Polypharmacy especially in elderly is a challenging public health problem all over the world that leads to increased hospitalization, poor quality of life and represents an economic burden especially in developing countries like Egypt. Objectives: To estimate the prevalence of polypharmacy and identify associated factors among elderly persons. Method: A descriptive, cross-sectional study conducted from August to December 2017, in Benha city, Qalubiya Governorate, Egypt. Study population is 60 years elder and over. They were interviewed by the researcher using a standardized valid questionnaire. Results: A total of 300 elderly persons were enrolled. Approximately 67%aged between 60 and 70 years, 73.7%of them live with their families, and 51.7% of them had a monthly income more than 2000 LE, 80% of them was non-smokers, and 85.3% of them reported using five or more medications. Logistic regression revealed that the significant predictors of polypharmacy use were sex (adjusted Odds Ratio (aOR), 0.1; 95% CI 0.04-0.28, p <0.001), residence (aOR, 3.29; 95% CI 1.18-9.14, p = 0.02), monthly income (aOR, 0.33; 95% CI 0.13-0.18, p = 0.02) and co-morbidity (aOR, 2.56; 95% CI 1.75-3.74, p <0.001). On the other hand, polypharmacy was not significantly associated with age (aOR, 0.84; 95% CI 0.34-2.07, p =0.71), smoking (a OR, 0.83; 95% CI 0.23-2.88, p =0.77), educational level (a OR, 1.19; 95% CI 0.62-2.29, p =0.59) or marital status (aOR, 0.71; 95% CI 0.47-1.07, p=0.1) Conclusion: The prevalence of polypharmacy was 85.3%. Sex, residence, monthly income and co-morbidity were significant predictors of polypharmacy.
Introduction
World Health Organization (WHO) report anticipated that between 2015 and 2050, the percentage of the world's population over 60 years will nearly double from about 12% to 22%. 1 Egyptian census 2017, reported that people above 60 years represented 6.9% of total Egyptian population. 2 Elderly people usually suffer from multiple co-morbidities and, as a result, become exposed to multiple drugs; this situation is often referred to as "polypharmy". 3 Polypharmacy is defined as the use of several different medications by one patient at the same time. 4 Sometimes it is estimated it to be 2 to 5 drugs, but the most commonly used definition is the simultaneous utilization of 5 to 7 drugs 3 and over seven medications is termed excessive polypharmacy. 5 Polypharmacy especially in elderly is a challenging public health problem all over the world. 1 Geriatric patients regularly experience the ill effects of changed pharmacokinetics, lessened medication clearance, and cognitive deficits. 6 Accompanying utilization of various medications may result in higher adverse drug reactions, drug-drug interaction and bring down adherence to treatment and cognitive decline. 7 In addition to increase need for care, higher healthcare cost and elevated hospital admission rate. 4 An adverse drug event is defined as "an injury due to a medication," and occurs in approximately (35 %) of elderly outpatients and (40 %) of elderly hospitalized patients. 8, 9 The most common type of ADE is an adverse drug reaction (ADR), which is characterized as a noxious and unintended response that occurs at normal doses of a medication. 10 ADRs may be Type A or Type B reactions. Type A reactions are related to the mechanism of action, for example, bleeding on warfarin, and this may occur if drug interactions increase medication's plasma levels. Type B reactions are random, like anaphylaxis. The risk of ADRs is (15%) with two medications and rises to (58%) with five medications and (82%) with over seven medications. The four most common drug groups associated with preventable drug-related admissions are anti-platelets; diuretics; NSAIDs and anti-coagulants. 11 The prevalence of polypharmacy in the elderly had been assessed by many studies. It ranged between (39%) 12 and (45%) 13 in developed countries. Egyptian study estimated it to be (56%) in rural communities 14 , but still there is rarity in studies evaluating the prevalence of polypharmacy in developing countries and to our knowledge, it is the first study estimating the prevalence of polypharmacy in Benha city, Qalubiya Governorate.
Method
Study design: This is a descriptive crosssectional multicenter study conducted in Benha city, Qalubiya Governorate, Egypt between August and December 2017. Sample size: The sample size was calculated using EPI-Info (Epidemiological information package) software version 6.1, C.I (Confidence Interval) 95%, Power 80%. The sample was 271 people we increase 10% so the sample size needed was 300 people. Data collection methods: The researcher used the face-to-face structured interview approach, based on standardized questionnaire. The data for analysis was collected from patients in different health care institutions including Benha University Hospital and Health Insurance clinics. Sample selection: The study sample was selected according to certain inclusion criteria: Being 60 years old or more, Be a resident of Banha city, The patients had at least one chronic pathological condition in the following clusters: cardio-metabolic (consisting of diabetes, heart disease or hypertension), musculoskeletal (consisting of arthritis or osteoporosis), and respiratory (consisting of COPD or asthma), GIT (hepatic or gastric diseases) and psychological disorders (depression and sleep disorders), Have been taking at least two drugs on regular base in the last six months and His health condition is stable and he is not a hospital resident at the time of study. For five months, study participants were selected from elderly attending out-patient clinics. The researcher interviewed patients on Saturday and Tuesday at Banha University Hospital and on Sunday and Wednesday at health insurance clinics.
Patients were interviewed in front of the drug dispensary. At the beginning of each day of the data collection period, the first patient was selected randomly then every 10 th patients was chosen in order to have time to interview selected ones. The time of interview was ranged between (5-10 minutes). The selected patient was asked to participate in this study and in case of agreement, we explained the purpose of the study and confirmed that all the patient's data is surrounded by confidentiality and the patient is entitled to remain anonymous if he wants. Sometimes care givers were allowed to help participants respond to questions. The average number of interviewed patients was (3-5) per day. The total interviewed patients were (327) patients, and after exclusion of incomplete sheets (some patients refused to answer questions related to monthly income or could not remember the name of all drugs) we finally had 300 sheets valid for coding and further analysis. Those with cognitive deficit or a condition that prevented answering the questionnaire were excluded from the start. Data collection tool: The questionnaire was pre-tested on 10 participants as a pilot study prior to the gross data collection which was not included in our results, and relevant modifications were instituted prior to commencement of actual data collection. The questionnaire contained socio demographic data, including gender, age, and marital status, place of residents, education level, monthly income, health status of the patient and behaviours and complications of drug use. The used questionnaire was validated in previous study. 15 We classified patients to two groups according to the number of taken drugs, polypharmacy group (5 drugs or more) & no-polypharmacy group (less than 5 drugs). 
Statistical analysis
The collected sheets were divided into two groups each of (150 sheets). Every researcher was responsible of one group for easier, faster and more accurate data entry ,and this was according to predetermined code. Data were tabulated, coded and analyzed using the Statistical Package for the Social Sciences (SPSS) software version 20.0 for Windows. Qualitative data were expressed in number and percentage. The statistical significant differences in polypharmacy and factors affecting it were done with Chi square test (X 2 ). Logistic regression analysis was done to detect predictors of polypharmacy. P value <0.05 was considered significant.
Ethical Considerations
Ethical approval was granted by ethical committee at Benha Faculty of Medicine and verbal consent was also obtained from each participant before conducting interview. Participants were told that the obtained information is confidential.
Results
As table (1) shows, among the 300 elderly persons surveyed, 66.7% were between 60 and 70 years old, 54% were males, 73.7% live with their families, 51.7% had income more than 2000 LE, and 80% were nonsmokers. In addition, 38% had university education, while 18.7% were illiterate. The median (IQR) for co-morbidities was 4 (2%). In terms of polypharmacy, 256 (85.3%) individuals reported using five or more medications (Table 1) . (Table 2 ) revealed the statistically significant difference between polypharmacy and non-poly-pharmacy groups regarding age (most of non-poly-pharmacy group belonged to the age group 60-70 
Discussion
In this study, the prevalence of polypharmacy was 85.3%, which is nearly similar to the results of previous studies conducted in Mexico 16 , Abu Dhabi 17 & Saudi Arabia 18 (84.5%, 89%and 89% respectively). On the contrary, our rate was higher than that of a previous Egyptian study estimated it to be 56% in rural communities 14 and another study performed in elderly patients on discharge from a tertiary care hospital in Oman which found it (76.3%). 4 The high rate of polypharmacy among our study group can be attributed to many factors like multiple co-morbidities they have, the culture of taking medications without medical prescription, easy access to over-the-counter medicines and higher socioeconomic condition in urban areas in comparison to rural ones which enable elderly people to have medications at their own expense. Though the high socioeconomic standard in developed and Arab countries in Gulf area, but there is very strict supervision on private pharmacy which limits easy access to over the counter medications. This study found a significant difference between polypharmacy & no polypharmacy group regarding age, sex, educational level, monthly income, marital status & co-morbidities. Polypharmacy group was older, male more than female, of lower educational level, lower monthly income, the majority were widows with multiple co morbidities > 4. Some of our findings come in agreement with results of previous studies reported a significant association between polypharmacy and sex 19 level of education, and/or a history of diabetes or hypertension. 20 Patient conduct and understanding can affect polypharmacy. Deprived knowledge about medication may lead to extra or needless drugs by physicians who don't know patients' current or previous medication list, this may be due to movement of patients between primary and secondary care. That result in a 'prescribing cascade', in which new symptom appears and the physicians don't know its source and write another drug for it and so on. Visiting more than one physician in different sites also rise the risk of repeated medications or drug interactions. 21 This study results differed from another study found no association between polypharmacy and age, sex, educational level, or number of co-morbidities. These differences could be the result of differences in the characteristics of the populations studied and/or sample size.
Limitations of this study
Inability to generalize the results of this study for elderly in different countries due to socio-demographic & economic variations and multiple accepted definitions of polypharmacy.
Conclusion
Polypharmacy is a common phenomenon among old males, with low educational level. The majority of polypharmacy group were widows with multiple co-morbidities (≥ 4 diseases). Sex, residence, monthly income and number of co-morbidities are significant predictors of this phenomenon.
Recommendations
Ministry of health should strictly supervise private pharmacies to limit over-thecounter medicines and recent medical prescription should be mandatory for having drugs. Also, periodic medical evaluation must be done especially for old people with multiple chronic diseases to minimize the amount of taken medications as possible as we can to decrease drug interaction.
